2021 CRI Meeting Abstracts

First Place

Electronic Source Documentation in Epic Reduces Key Audit Findings and Aids in Remote Coordinating and Auditing [Abstract] [Poster]
N. Kurtzweil, M. Marcum, T. Wise-Draper
University of Cincinnati Cancer Center 

Second Place

A Catalyst for Success: How the I2T3 is Transforming IIT Development at UFHCC [Abstract
E. Monari, A. Ivey, T. George, A. Anderson 
University of Florida Health Cancer Center

Third Place

Doing More With Less: The Adoption of Slot Management Practices to Drive Resource Allocation in the Clinical Trials Office [Abstract] [Poster]
C. Gregor
Vanderbilt-Ingram Cancer Center
 


Abstracts are organized by category, in alphabetical order by cancer center.
 

Categories:
Clinical Trial Operations
Finance/CCSG/PRMS
Investigator-Initiated Trials
Regulatory
Training, Quality Assurance, Remote Monitoring, and Auditing
Trial Recruitment & Community Outreach and Engagement
Trial Start-up and Activation

 

Clinical Trial Operations
1. Operationalizing a New Therapy Across Research Groups: A Team-Based Approach to Managing CAR T Clinical Trials [Abstract]
L. Waitkus
Cleveland Clinic Cancer Center

2. COVID Response: Providing Ongoing Oncology Clinical Research Support During a Pandemic [Abstract
B. Oleson, J. Thomas, J. Bollmer, K. Schroeder, D. Pastorek, P. Jacobs, M. Pigsley, S. Zindars, G. Coly
Medical College of Wisconsin Cancer Center

3. Automating Protocol Training Documentation: Regulatory Compliance in a Click [Abstract
R. Lehrman, P. Lim, C. Abate, J. Buthorn, A. Foster, E. Hamilton, H. Kiesler, K. Yataghene
Memorial Sloan Kettering Cancer Center

4. Clinical Trial Finder - A Comprehensive Mobile Application [Abstract
D. Mudaranthakam, V. Murakonda, A. Tribitt, J. Scott, B. Broome, J. Thompson, M. Mayo, B. Gajewski, T. Lin
The University of Kansas Cancer Center

5. OPTIK - Organize Prioritize Trends to Inform KU Cancer Center Members [Abstract
D. Mudaranthakam, L.M. Harlan-Williams, H. Krebill, H. Kuo, D. Koestler, Q. Xia, R. Chen, L. Chollet-Hinton, M. Mayo, R. Jensen
The University of Kansas Cancer Center

6. Cross-Modality Reconciliation for Management and Reporting of All Cancer-Related Clinical Research Data [Abstract] [Poster]
C. Serway, E.D. Merchasin, R.C. Compton, U. Brown-Glaberman, C.Y. Muller
University of New Mexico Comprehensive Cancer Center

7. We Have 99 Problems But a Participant Withdraw is No Longer One [Abstract
S. Bigelow, C. Galasso, J. Ventimiglia, L. Casetta, C. Zuccaro, J. Mancini
Barbara Ann Karmanos Cancer Institute, Wayne State University

8. Executing a Healthy Volunteer Study During COVID-19 Pandemic [Abstract
P. Herena, M. Licata, R. Stan, C. Wood, A. Yi, M. Shields
City of Hope Comprehensive Cancer Center

9. Increasing the Utilization and Efficiency of a Phase 1 Program to Support Pan-Tumor Clinical Trials [Abstract]
J. Tomer, K. Gardner, J. Southard
Cleveland Clinic Cancer Center

10. Harness the Power of Automation for Clinical Research Management [Abstract] [Poster]
D. Wilson, R. Kingsford, L. Hayes, J. Moehle, T. Werner
Huntsman Cancer Institute, University of Utah

11. A Quality Connection… An Enhanced Leadership Structure Through the Implementation of a Project Administrator [Abstract] [Poster]
L. Lujan, S. Sharry, R. Kingsford, J. Moehle
Huntsman Cancer Institute, University of Utah

12. Smooth Sailing... Cellular Immunotherapy Trials Collaboration and Integration Process [Abstract] [Poster]
S. Sharry, C. Cromar, K. Hicks, L. Lujan, J. Moehle, K. Pena
Huntsman Cancer Institute, University of Utah

13. Team Connection During COVID [Abstract] [Poster]
J. Espinosa, C. Marshall, A. Horstmeier, J. Moehle, L. Lujan
Huntsman Cancer Institute, University of Utah

14. * There and Back Again: A Satellite Site Operations Tale [Abstract
B. Glenn, K. Stephens, A. Horstmeier, E. D'Astous, J. Moehle, T. Werner
Huntsman Cancer Institute, University of Utah

15. Establishing an Employee Engagement, Equity, and Education Committee During Remote Operations [Abstract
J. Feola, M. Kimber, A. Hoeschen, M. Dworak, M. Loza
Masonic Cancer Center, University of Minnesota

16. Transformative Lessons for Clinical Trials From the COVID-19 Pandemic: Remote Monitoring, Virtual Research Visits, and Added Flexibility for Patients [Abstract
G. Malave, A. Fritsche, K. Croghan, J. Jensen, J. Burton, J. Pickett, H. Finnes, J. Judge, J. Bruggeman, J. Welter, S. Alberts, S. Kumar
Mayo Clinic Cancer Center

17. Structured Collaboration With Clinical Partners to Enhance Research Participant Safety and Experience Along With Protocol Compliance and Expeditious Trial Activation [Abstract] [Poster
S. Willoughby, C. Davis
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

18. Incorporating the Complexity of Screening Into Protocol Acuity: Updates to the SCCC Staff Scoring Model [Abstract] [Poster]
E. Siglinsky, K. Crane, S. Grant, S. Meletath, A. Neal, H. Phan, S. Goksu, M.S. Beg, E. Williams
Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

19. Does Mentorship Improve CRC Retention Rates and Employee Satisfaction? [Abstract] [Poster]
E. Pon, E. Nurminen, M. Welsh, M. Narwal
UCSF Helen Diller Family Comprehensive Cancer Center

20. Transitioning to Remote Monitoring Visits at the Helen Diller Family Comprehensive Cancer Center [Abstract
M. Kock
UCSF Helen Diller Family Comprehensive Cancer Center

21. From Take-Off to Landing: The Creation and Implementation of a CCPS Navigator Resource [Abstract
A. Trainor, A. Ivey, T. George, L. Pettiford, A. Anderson
University of Florida Health Cancer Center

22. Implementation of Electronic Informed Consent for Cancer-Relevant Clinical Trials at the UFHCC [Abstract] 
A. Riggs, T. Toon, A. Anderson, A. Ivey, T. George
University of Florida Health Cancer Center

23. Doing More With Less: The Adoption of Slot Management Practices to Drive Resource Allocation in the Clinical Trials Office [Abstract] [Poster]
C. Gregor
Vanderbilt-Ingram Cancer Center

24. Adapting Adverse Event Log Creation During COVID-19: Development of the Winship eAE Log Application [Abstract] [Digital Presentation]
D. Smith, M. Ellingson, V. Parker, M. Martin, T. Adewuya, P. Bourbo, S. Brown, L. Cox, M. Williams, L. Floyd, B. Gamble, M. Hananel, T. Kurilo, A. Lesinski, K. Nguyen, C. Shah, C. Sharp, A. Trumbull, A. Overby, M. Behera
Winship Cancer Institute of Emory University


Back to top

Finance/CCSG/PRMS

25. Staff Effort Estimate Calculator: A Successful Multisite Program Budget and Staffing Tool [Abstract] [Poster]
A. Hinman, A. Baim, A. Carabajal, R. Selle, B. Oleson, J. Thomas

Medical College of Wisconsin Cancer Center

26. Statistically Significant Impacts of a PRMC Charter Alignment With NCI Practices [Abstract] [Poster]
C. Vollmer, T. Herzog, C. Allen, N. Kurtzweil, E. Chandra, B. Hughes

University of Cincinnati Cancer Center

27. * MSK’s NCI Network Program [Abstract] [Poster]
J. Mohr, L. Gaffney, C. Houston, M. Warren, C. Aghajanian, P. Sabbatini, E. Cottington, S. Ramaswami, B. Zakrzewski, J. Klinger, S. Dominguez, S. Terzulli, J. Nunner, A. Rodavitch, K.R. Simpson, S. Hanley

Memorial Sloan Kettering Cancer Center

28. Enhancing the DSG Review at the UFHCC [Abstract
J. Walsh, T. Guinn, A. Anderson, A. Ivey, T. George

University of Florida Health Cancer Center

Back to top

Investigator-Initiated Trials

29. * Use of R-Scripts Can Help to Decrease Time and Improve Accuracy on Summary Tables for IND and Semi-Annual Reports [Abstract] [Poster]
B. Palmer, A. Brikha, F. Lin, J. Woodman

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

30. Managing Investigator-Initiated Clinical Trials Registration to Reduce Overall Reporting Errors at a Consortium Cancer Center [Abstract
K. Hoy, A. Savadelis, A. Firstencel, H.J. Pounardjian

Case Comprehensive Cancer Center

31. Development, Management, and Oversight of Investigator-Initiated Multicenter Trials [Abstract
J. Walkley, M. Warren, K. Muenkel, S. Hughes, C. Friedman, C. Houston

Memorial Sloan Kettering Cancer Center

32. A Catalyst for Success: How the I2T3 is Transforming IIT Development at UFHCC [Abstract
E. Monari, A. Ivey, T. George, A. Anderson

University of Florida Health Cancer Center

Back to top

Regulatory

33. Implementation of a Fully Electronic Regulatory Binder for Clinical Trials During COVID Pandemic [Abstract
C. Kennedy, B. Sharp, K. Penas
Fred and Pamela Buffett Cancer Center

34. Fast Financials: An Automated Approach to Financial Disclosures [Abstract
A. Foster, J. Buthorn, A.M. Gonzalez-Dadiz, K. Yataghene
Memorial Sloan Kettering Cancer Center

35. Regulatory Team Increasing Efficiency and Reducing Footprint in the Office [Abstract
C. Vollmer
University of Cincinnati Cancer Center

36. Partnering With Foreign Collaborators and the Institutional Review Board to Document Human Subjects Protection Requirements for Sites Outside of the United States [Abstract
V. Santana, L. Faughnan, E. Fernandes, K. Prive, P. Naidu
Comprehensive Cancer Center St. Jude Children's Research Hospital

37. * Developing a Tool to Assess Regulatory Acuity and Workload [Abstract] [Poster]
M. Kannon, S. Scott
UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

38. Regulatory Completion Timelines: A Prospective and Retrospective Analysis of the Effect of an eRegulatory System [Abstract]
M. Kannon, S. Scott, J. Sweitzer, K.M.C. Blalock, P. Brock, A. Ciccotti, S. Williams, C. Worth
UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

39. Implementing the Shared Investigator Platform at the UFHCC [Abstract
A. Anderson, T. Toon, A. Ivey, T. George
University of Florida Health Cancer Center

Back to top

Training, Quality Assurance, Remote Monitoring, and Auditing

40. Maintaining Specimen Compliance for a High Volume of Complex Clinical Trials [Abstract
C. Johnston, A. Larsen, J. Cummings, J. Moehle

Huntsman Cancer Institute, University of Utah
 

41. Risk-Based Monitoring (RBM) Model: Safeguarding Single-Center, Investigational New Drug (IND), Investigator-Initiated Trials (IIT) at Memorial Sloan Kettering Cancer Center [Abstract
F. Puma, A. Granobles, K. Mantha-Thaler, K. Yataghene

Memorial Sloan Kettering Cancer Center

42. Saved by Automation! How Technology and Innovative Thinking Significantly Increased Productivity of the MSK CR Audit Program [Abstract] [Poster]
S. Puleio, J. Simpronio

Memorial Sloan Kettering Cancer Center

43. Strengthening Monitoring/Auditing Collaboration With Sponsors [Abstract] [Poster]
A. Granobles, F. Puma, K. Yataghene, K. Mantha-Thaler, N. Cimaglia
Memorial Sloan Kettering Cancer Center

44. Demonstrating Safety and Necessity of Clinical Trials Deviations for Improving Flexibility and Inclusivity of Clinical Trials Enrollment Utilizing a Centralized Deviation Database [Abstract
M. Hullings, E. Williams, P. Dixit, C. Wynne-Jones, A. Gonzalez, M.S. Beg, D. Gerber

Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

45. Creation of a Sponsor Quality Management Plan Under GCP Revision 2: Checks-and-Balances, Quality Systems, and Cross-Functional Communication [Abstract
J. Morrison, M. O'Dwyer, C. Conde, S. Maxwell, N. Babadi, R. Johnson, M.A. Kannon, S. Scott, J. Huamani-Bundy, C. Lee

UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

46. Electronic Source Documentation in Epic Reduces Key Audit Findings and Aids in Remote Coordinating and Auditing [Abstract] [Poster]
N. Kurtzweil, M. Marcum, T. Wise-Draper

University of Cincinnati Cancer Center

47. Remote Onboarding and Training in the Clinical Trials Office [Abstract
K. Rygalski, M. Russell, D. Kitterman

University of Illinois Cancer Center

48. Reducing Turnover During a Pandemic: Growing Leaders at an NCI-Designated Cancer Center [Abstract]
A. Rice-Warren, C. Fournier

Duke Cancer Institute, Duke University Medical Center

49. Transitioning to Remote Monitoring: Challenges and Successes [Abstract] 
H. Finch, S. Matkin, K. Thorne

Huntsman Cancer Institute, University of Utah

50. * Equity and Diversity Initiatives Within a Cancer Center's Clinical Trials Office [Abstract] [Poster]
M. Dworak, M. Loza, D. Berkow-Schwartz

Masonic Cancer Center, University of Minnesota

51. Rolling With the Changes: Onboarding Staff Remotely During the COVID-19 Pandemic [Abstract
R. Selle, M. Gray, B. Oleson, J.P. Thomas
Medical College of Wisconsin Cancer Center

52. Onboarding and Training New Staff While Working Remote During a Global Pandemic [Abstract] [Poster]
E. Laskowski, J. DeJong, H. Apell

The University of Kansas Cancer Center

53. Ensuring the Next Generation of Clinical Researchers [Abstract
A. Anderson, L. Pettiford, A. Ivey, T. George

University of Florida Health Cancer Center

54. Implementation of a Research-Specific, Electronic Orientation for Clinical Research Professionals [Abstract
A. Kukulka, A. Ivey, A. Anderson, T. George

University of Florida Health Cancer Center

55. Implementation of Professional Competency Development Program for Clinical Research Professionals [Abstract
A. Kukulka, A. Ivey, A. Anderson, T. George

University of Florida Health Cancer Center

Back to top

Trial Recruitment & Community Outreach and Engagement 

56. * Exploring the Perceptions and Satisfaction of Princess Margaret Clinical Trial Participants [Abstract
K. Zeman, S. Sellmann, H. Cole
Princess Margaret Cancer Centre, University Health Network

57. Strengthening Connections: Integrating Clinical Trials Into Patient and Public Education [Abstract] [Poster]
G. Nachaegari, S. Fraser, D. Branson, J. Moehle, T. Werner
Huntsman Cancer Institute, University of Utah

Back to top

Trial Start-up and Activation

58. Use of a Site Profile to Streamline Site Selection and Feasibility [Abstract
S. Zindars, J. Bollmer, B. Oleson, K. Schroeder, D. Pastorek, M. Pigsley, P. Jacobs, G. Coly, R. Selle, B. Steinert, A. Carabajal
Medical College of Wisconsin Cancer Center

59. One Committee to Review Them All: A Single, Multidisciplinary COVID-19 Research Committee [Abstract] [Poster]
J. Migliacci, S. Hanley, A. Rodavitch
Memorial Sloan Kettering Cancer Center

60. Study Start-up Activation Dashboard - Improving Transparency [Abstract] [Poster]
L. Wall, A. Spratt, N. Connellan
The University of Chicago Medicine Comprehensive Cancer Center

61. * Strategies for Improving Time-to-Activation of Clinical Trials [Abstract
J. Plassmeyer, B. Marino, M. Yarkowski, M. Horak, H. Usman, D. Cleary, A. Wozniak, B. Pappu
UPMC Hillman Cancer Center

62. Process Improvements to Shorten Clinical Trial Activation Times Within a National Cancer Institute-Designated Comprehensive Cancer Center [Abstract
S. Grant, M. Farmer
Wake Forest Baptist Comprehensive Cancer Center

Back to top

*Honorable Mention